company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,42952000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,236145000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3472000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,282569000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5168000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2130000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2130000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,,totalassets,Total Assets,=,debit,usd,289867000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,315000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1461000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2552000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,105000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3352000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,7785000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,9269000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,128000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,9397000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,17182000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,890314000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-617689000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,60000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,272685000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,272685000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,272685000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,,2011-06-30,2011-08-02 08:00:54+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,289867000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,18682000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,247000000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2910000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,268592000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5223000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2050000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2050000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,,totalassets,Total Assets,=,debit,usd,275865000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,134000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1275000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2496000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4517000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8422000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,9356000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,123000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,9479000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,17901000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,893606000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-635620000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-22000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,257964000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,257964000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,257964000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,,2011-09-30,2011-11-01 08:01:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,275865000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,22033000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,201267000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2775000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,226075000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5904000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1932000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1932000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,,totalassets,Total Assets,=,debit,usd,233911000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1922000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2770000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,262000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3085000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8039000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,9180000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,112000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,9292000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,17331000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,901136000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-684581000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,25000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,216580000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,216580000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,216580000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,,2012-03-31,2012-05-01 08:00:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,233911000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,26151000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,176488000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3734000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,206373000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6112000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1875000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1875000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,,totalassets,Total Assets,=,debit,usd,214360000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1912000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3518000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,397000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3673000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9500000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,9003000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,107000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,9110000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,18610000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,905032000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-709319000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,37000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,195750000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,195750000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,195750000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,,2012-06-30,2012-08-07 08:00:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,214360000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,26801000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,157094000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2734000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,186629000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5861000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1826000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1826000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,,totalassets,Total Assets,=,debit,usd,194316000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1388000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3267000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,531000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,5399000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10585000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,8825000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,102000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,8927000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,19512000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,909473000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-734775000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,106000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,174804000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,174804000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,174804000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,,2012-09-30,2012-11-06 08:00:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,194316000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,34159000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,238291000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2955000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,275405000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5833000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1701000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1701000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,,totalassets,Total Assets,=,debit,usd,282939000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2138000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,873000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,801000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3271000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2075000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9158000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,8379000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,91000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,8470000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,17628000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1051054000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-785821000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,78000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,265311000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,265311000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,265311000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,,2013-03-31,2013-05-07 12:55:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,282939000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,21868000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,229773000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2935000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,254576000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5454000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1644000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1644000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,,totalassets,Total Assets,=,debit,usd,261674000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2121000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2711000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,937000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2703000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8472000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,8066000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,85000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,8151000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16623000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1053623000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-808589000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,17000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,245051000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,245051000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,245051000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,,2013-06-30,2013-08-06 12:44:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,261674000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,16031000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,214851000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2131000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,233013000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4938000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1586000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1586000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,,totalassets,Total Assets,=,debit,usd,239537000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1025000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3331000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1073000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2874000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8303000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,7752000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,80000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,7832000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16135000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1055686000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-832413000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,129000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,223402000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,223402000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,223402000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,,2013-09-30,2013-11-05 08:01:10+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,239537000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,14910000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,180474000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2444000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,197828000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3978000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1484000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1484000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,,totalassets,Total Assets,=,debit,usd,203290000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1157000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2883000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1350000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2475000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,7865000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,7029000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,69000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,7098000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,14963000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1059866000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-871577000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,38000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,188327000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,188327000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,188327000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,,2014-03-31,2014-05-07 13:46:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,203290000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,23882000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,152148000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1510000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,177540000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3430000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1461000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1461000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,,totalassets,Total Assets,=,debit,usd,182431000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1896000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3501000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1496000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3172000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10065000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6570000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,63000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,6633000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16698000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1062659000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-896968000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,42000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,165733000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,165733000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,165733000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,,2014-06-30,2014-08-05 13:20:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,182431000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,12814000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,144858000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1271000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,158943000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2862000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1414000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1414000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,,totalassets,Total Assets,=,debit,usd,163219000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1018000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3906000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1641000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3636000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10201000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6111000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,57000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,6168000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16369000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1064744000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-917910000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,16000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,146850000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,146850000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,146850000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,,2014-09-30,2014-11-04 13:46:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,163219000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,42718000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,118437000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,106000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1261000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,162522000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2106000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1061000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1061000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,,totalassets,Total Assets,=,debit,usd,165689000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1136000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5440000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,24059000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3714000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,34349000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,5734000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,13412000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,46000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,19192000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,53541000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1070506000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-958375000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,17000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,112148000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,112148000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,112148000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,,2015-03-31,2015-05-07 16:14:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,165689000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,17290000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,126652000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,350000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1230000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,145522000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1810000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1021000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1021000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,,totalassets,Total Assets,=,debit,usd,148353000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1096000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4838000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,24240000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4000000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,34174000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,4989000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,8000000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,39000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,13028000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,47202000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1073427000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-972287000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,11000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,101151000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,101151000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,101151000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,,2015-06-30,2015-08-04 16:10:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,148353000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,38577000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,95773000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,163000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1667000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,136180000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1817000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1173000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1173000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,,totalassets,Total Assets,=,debit,usd,139170000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,689000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6440000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,23348000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4361000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,34838000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,4231000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3662000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,33000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,7926000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,42764000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1075340000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-978959000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,25000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,96406000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,96406000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,96406000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,,2015-09-30,2015-11-03 16:28:37+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,139170000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,14269000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,89363000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,195000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1779000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,105606000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1610000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1064000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1064000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,,totalassets,Total Assets,=,debit,usd,108280000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2424000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8086000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,14049000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3152000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,27711000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,2675000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2421000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,21000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,5117000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,32828000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1084513000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1009110000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,49000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,75452000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,75452000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,75452000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,,2016-03-31,2016-05-03 16:22:40+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,108280000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,24946000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,69994000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,95000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1862000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,96897000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1581000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,842000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,842000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,,totalassets,Total Assets,=,debit,usd,99320000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1506000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7971000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9405000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3119000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,22001000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,1877000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1707000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,15000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,3599000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,25600000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1096310000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1022643000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,53000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,73720000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,73720000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,73720000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,,2016-06-30,2016-08-02 16:16:13+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,99320000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,25950000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,59305000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1292000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,86547000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1294000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,800000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,800000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,,totalassets,Total Assets,=,debit,usd,88641000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1518000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8727000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,5835000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4552000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,20632000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,1064000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,994000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,8000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,2066000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,22698000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1111206000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1045272000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,9000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,65943000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,65943000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,65943000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,,2016-09-30,2016-11-01 16:21:31+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,88641000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,40144000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,57997000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1383000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,99524000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1072000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,730000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,730000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,,totalassets,Total Assets,=,debit,usd,101326000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1178000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7702000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,5744000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2621000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17245000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,17245000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1160286000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1076176000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-29000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,84081000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,84081000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,84081000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,,2017-03-31,2017-05-02 16:02:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,101326000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,32591000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,49711000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1490000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,83792000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,982000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,704000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,704000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,,totalassets,Total Assets,=,debit,usd,85478000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2066000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6167000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3981000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3659000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,15873000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,15873000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1164947000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1095323000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-19000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,69605000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,69605000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,69605000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,,2017-06-30,2017-08-01 16:01:44+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,85478000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,25879000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,42197000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1485000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,69561000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,919000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,770000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,770000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,,totalassets,Total Assets,=,debit,usd,71250000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2193000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5925000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2145000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4743000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,15006000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,77000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,77000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,15083000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1169157000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1112983000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-7000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,56167000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,56167000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,56167000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,,2017-09-30,2017-11-07 16:06:07+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,71250000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,40125000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,54175000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2320000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,96620000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1439000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,754000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,754000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,,totalassets,Total Assets,=,debit,usd,98813000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2623000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,11421000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4746000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,18790000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,178000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,38000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,216000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,19006000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1243133000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1163239000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-87000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,79807000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,79807000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,79807000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,,2018-03-31,2018-05-01 16:06:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,98813000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,65078000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,69914000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1620000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,494000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1551000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,400000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,139057000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1484000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,678000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,678000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,,totalassets,Total Assets,=,debit,usd,141219000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3342000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8583000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,5440000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17365000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,249000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,38000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,287000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,17652000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1312412000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1188796000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-49000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,123567000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,123567000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,123567000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,,2018-06-30,2018-08-08 16:11:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,141219000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,61486000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,54151000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3273000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,534000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1562000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,30000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,121036000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1481000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,652000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,652000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,,totalassets,Total Assets,=,debit,usd,123169000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2641000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9556000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,7499000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,19696000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,19696000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1316060000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1212562000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-25000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,103473000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,103473000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,103473000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,,2018-09-30,2018-11-06 16:06:32+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,123169000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,74696000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,53227000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5614000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1130000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4652000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,139319000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1600000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,31865000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,31865000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,,totalassets,Total Assets,=,debit,usd,172784000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1179000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,13754000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1532000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4432000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,5241000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,26138000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,24950000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,26381000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,51331000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,77469000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1322237000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1226932000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,10000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,95315000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,95315000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,95315000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,,2019-03-31,2019-05-07 16:06:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,172784000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,44229000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,68148000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6933000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1222000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3972000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,124504000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1532000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,30122000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,30122000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,,totalassets,Total Assets,=,debit,usd,156158000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3777000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,10376000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1362000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,5863000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,7002000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,28380000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,23086000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,26401000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,49487000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,77867000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1325786000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1247538000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,43000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,78291000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,78291000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,78291000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,,2019-06-30,2019-08-06 16:09:23+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,156158000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,39093000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,68387000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,11552000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1181000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5789000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,126002000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1718000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,28341000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,28341000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,,totalassets,Total Assets,=,debit,usd,156061000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2661000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12437000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1587000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,7066000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,7255000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,31006000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,9789000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,21179000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,25176000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,56144000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,87150000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1327903000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1259028000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,36000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,68911000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,68911000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,68911000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,,2019-09-30,2019-11-05 16:15:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,156061000.0
